MYCOD
Mydecine Innovations Group Inc - Ordinary Shares New

1,269
Price
$0.185
Volume
16.00
Prev Close
$0.135
Open
$0.17
EPS (Annual)
-$1.93
MYCOD Fundamentals
Loading...
Loading...
Mydecine Innovations Group, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Mydecine Innovations Group Inc - Ordinary Shares New stock price today?
What was Mydecine Innovations Group Inc - Ordinary Shares New stock price yesterday?

Latest MYCOD News

View
No MYCOD news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.